Amy Comstock Rick: key facts
- Kind of voice
- Sector leader
- Role
- Director, Rare Disease Innovation Hub
- Quoted on
- Rare diseases
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
“We are committed to a continued, transparent dialogue with the rare disease community, which is essential for establishing trust and keeping pace with the rapidly evolving and complex nature of the rare disease space.”
What Amy Comstock Rick has said
“Rare disease has been a priority for the FDA since the Orphan Drug Act of 1983... but with the MAHA report's emphasis on common, chronic diseases, 'rare may not have had the level of prioritization they've had before.'”
associate director for Rare Disease Strategy and director of Strategic Coalitions at CDER's Rare Disease Innovation Hub · Rare diseases · 30 Sept 2026 · Through flux and fluidity, FDA keeps coming back to rare disease ↗
Where Amy Comstock Rick has been quoted
- Lessons Learned from our Roundtable with Rare Disease Advocatesfda.gov · 30 Sept 2026
- Through flux and fluidity, FDA keeps coming back to rare diseasebiospace.com · 30 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.